Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity.
Jasmina Vidic, Charles-Adrien Richard, Christine Péchoux, Bruno Da Costa, Nicolas Bertho, Sandra Mazerat, Bernard Delmas, Christophe Chevalier
文献索引:J. Biol. Chem. 291 , 739-51, (2016)
全文:HTML全文
摘要
PB1-F2 is a small accessory protein encoded by an alternative open reading frame in PB1 segments of most influenza A virus. PB1-F2 is involved in virulence by inducing mitochondria-mediated immune cells apoptosis, increasing inflammation, and enhancing predisposition to secondary bacterial infections. Using biophysical approaches we characterized membrane disruptive activity of the full-length PB1-F2 (90 amino acids), its N-terminal domain (52 amino acids), expressed by currently circulating H1N1 viruses, and its C-terminal domain (38 amino acids). Both full-length and N-terminal domain of PB1-F2 are soluble at pH values ≤6, whereas the C-terminal fragment was found soluble only at pH ≤ 3. All three peptides are intrinsically disordered. At pH ≥ 7, the C-terminal part of PB1-F2 spontaneously switches to amyloid oligomers, whereas full-length and the N-terminal domain of PB1-F2 aggregate to amorphous structures. When incubated with anionic liposomes at pH 5, full-length and the C-terminal part of PB1-F2 assemble into amyloid structures and disrupt membrane at nanomolar concentrations. PB1-F2 and its C-terminal exhibit no significant antimicrobial activity. When added in the culture medium of mammalian cells, PB1-F2 amorphous aggregates show no cytotoxicity, whereas PB1-F2 pre-assembled into amyloid oligomers or fragmented nanoscaled fibrils was highly cytotoxic. Furthermore, the formation of PB1-F2 amyloid oligomers in infected cells was directly reflected by membrane disruption and cell death as observed in U937 and A549 cells. Altogether our results demonstrate that membrane-lytic activity of PB1-F2 is closely linked to supramolecular organization of the protein. © 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
相关化合物
相关文献:
2015-02-05
[Chem. Biol. Interact. 227 , 7-17, (2015)]
2014-07-01
[Biochem. Pharmacol. 92(3) , 506-16, (2014)]
2015-01-01
[PLoS ONE 10(3) , e0121610, (2015)]
2015-03-01
[Antimicrob. Agents Chemother. 59(3) , 1680-9, (2015)]
2014-12-01
[Mol. Cell Biochem. 397(1-2) , 33-43, (2014)]